CITI/CALL/BRISTOL-MYERS SQUIBB/60/0.1/19.12.24

CITI/CALL/BRISTOL-MYERS SQUIBB/60/0.1/19.12.24 Share Price

DE000KH75JH7

Market Closed - Deutsche Boerse AG 11:10:53 28/06/2024 pm IST
0.001 ^EUR	0.00%

6 months	-99.47%
Current year	-99.47%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart BRISTOL-MYERS SQUIBB COMPANY

Chart CITI/CALL/BRISTOL-MYERS SQUIBB/60/0.1/19.12.24

Latest news about BRISTOL-MYERS SQUIBB COMPANY

Purple Biotech Says Interim Data from Pancreatic Cancer Drug Study Shows Promise	27/06	MT
2seventy bio Sells Hemophilia A Candidate, Gene Editing Technology to Novo Nordisk; Shares Rise After Hours	27/06	MT
Top Midday Stories: Southwest Cuts Q2 Guidance; HHS to Lower Costs for Medicare Enrollees on 64 Drugs; Bosch Weighing Acquisition Offer for Whirlpool; Novo Nordisk to Record $816.2 Million Impairment	26/06	MT
Biden Administration to Lower Costs for 64 Prescription Drugs for Medicare Enrollees	26/06	MT

More news

Quotes 5-day view

Date	Price	Change
28/24/28	0.001	0.00%
27/24/27	0.001	0.00%
26/24/26	0.001	0.00%
25/24/25	0.001	0.00%
24/24/24	0.001	0.00%

Delayed Quote Deutsche Boerse AG

Last update June 28, 2024 at 11:10 pm IST

More quotes

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	CALL
Underlying	BRISTOL-MYERS SQUIBB COMPANY
Issuer	Citi
WKN	KH75JH
ISIN	DE000KH75JH7
Date issued	18/07/2023
Strike	60 $
Maturity	19/12/2024 (173 Days)
Parity	10 : 1
Emission price	0.76 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	0.94 €
Lowest since issue	0.001 €

Company Profile

Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques. The United States account for 70.1% of net sales.

Sector

More about the company

Ratings for Bristol-Myers Squibb Company

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Consensus: Bristol-Myers Squibb Company

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

41.53 USD

Average target price

53.19 USD

Spread / Average Target

+28.09%

Consensus